Is Resmed Stock the Right Pick for Your Portfolio Now?

RMD expands mask and device sales while maintaining strong liquidity, but macro and competitive pressures loom.
Seeking Alpha

ResMed masks to remain on market despite recall: report

ResMed (NYSE:RMD) intends to keep its CPAP masks that utilize magnets on the market despite a recall because it regards the action as a labeling correction rather than a product removal. According to ...
AOL

ResMed says its masks to remain on market despite FDA classification

(Reuters) - ResMed said its respiratory masks containing magnets will remain on the market even though the U.S. Food and Drug Administration classified a recall of the product as most serious as their ...
Healio

ResMed CPAP masks subject to Class I recall over magnetic interference issue

Please provide your email address to receive an email when new articles are posted on . ResMed CPAP masks that contain magnets are being recalled due to possible magnetic interference with medical ...
Nasdaq

ResMed Enhances CPAP Therapy with its First Fabric Mask, Designed to Make it Easier for People to Embrace Their Treatment and Improve Overall Sleep Health

The new AirTouch™ N30i tube-up nasal mask for CPAP combines softness, breathability, and a high-performance, durable seal to provide exceptional comfort SAN DIEGO, Sept. 30, 2024 (GLOBE NEWSWIRE) -- ...
Morningstar

ResMed Mask and Accessories Resupply Fuels a FVE Upgrade Despite Coronavirus Impacting Near Term

ResMed is taking a “smart devices” and “big data” approach to further entrench itself as one of the two leading players in the global sleep apnea market. The strategy is two-fold – accelerating ...
Morningstar

ResMed Earnings: Strong Mask Sales and Cost Control Offset U.S. Device Softness

We maintain our USD 258 fair value estimate for narrow-moat ResMed RMD, or AUD 40 per CDI at current exchange rates, following first-quarter fiscal 2024 results. Underlying EBIT of USD 319 million ...
Times of San Diego

FDA: Voluntary Recall of CPAP Masks by San Diego’s ResMed Addresses ‘Serious’ Problem

The Food and Drug Administration on Thursday classified the voluntary recall of certain respiratory masks made by ResMed as “most serious” as their incorrect use could cause major injuries or death.
Nasdaq

ResMed Notifies Customers About Updated Instructions and Labeling for Masks with Magnets Due to Potential Interference with Certain Medical Devices

SAN DIEGO, Dec. 20, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) is conducting a voluntary global field action to update its guides for all masks with magnets to inform users about potential ...

ResMed: Waiting For The Next Catalyst, Initiating With Hold Rating

ResMed’s recurring revenue model leverages device sales, consumables, and SaaS, with growth driven by rising diagnosis and ...
Yahoo Finance

ResMed Inc. (RMD) Gains Analyst Confidence as Price Targets Rise on Strong Earnings

ResMed Inc. (NYSE:RMD) is one of the best medical technology stocks to invest in. On January 30, KeyBanc Capital Markets lifted its price target on ResMed Inc. (NYSE:RMD) to $302 from $299 and ...